NASDAQ: SCNI
Scinai Immunotherapeutics Ltd Stock Ownership - Who owns Scinai Immunotherapeutics?

Insider buying vs selling

Have Scinai Immunotherapeutics Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when SCNI insiders and whales buy or sell their stock.

SCNI Shareholders

What type of owners hold Scinai Immunotherapeutics Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Amir Reichman5.03%711,637,600$190.01MInsider
Elad Mark1.13%160,355,016$42.81MInsider
Mark Germain0.85%120,000,000$32.04MInsider
URI Benor0.24%33,329,004$8.90MInsider
George Lowell0.00%421,680$112.59kInsider
Morris C. Laster0.00%66,800$17.84kInsider
Yael Margolin0.00%66,800$17.84kInsider
Avner Rotman0.00%66,800$17.84kInsider
Adi Raviv0.00%66,800$17.84kInsider
Xtx Topco Ltd0.00%24,041$6.42kInstitution

1 of 2

SCNI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SCNI0.00%7.26%
NCNA0.00%0.01%
BDRX0.00%0.00%
AKTX0.00%4.87%Net BuyingNet Buying
JAGX2.50%97.50%

Scinai Immunotherapeutics Stock Ownership FAQ

Who owns Scinai Immunotherapeutics?

Scinai Immunotherapeutics (NASDAQ: SCNI) is owned by 0.00% institutional shareholders, 7.26% Scinai Immunotherapeutics insiders, and 92.74% retail investors. Amir Reichman is the largest individual Scinai Immunotherapeutics shareholder, owning 711.64M shares representing 5.03% of the company. Amir Reichman's Scinai Immunotherapeutics shares are currently valued at $196.41M.

If you're new to stock investing, here's how to buy Scinai Immunotherapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.